TrialSignal
Clinical trial intelligence report
Mother - Daughter Initiative (MDI) in Cervical Cancer Prevention
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 20, 2026
NCT ID
NCT01096134
Status
COMPLETED
Phase
NA
Sponsor
Jhpiego
Executive brief
Investment-Ready Snapshot
The Mother-Daughter Initiative (MDI) will test the feasibility and acceptability of a strategy to deliver comprehensive cervical cancer prevention services in Thailand and the Philippines by integrating the HPV vaccine for girls ages 9-13 into already successful screening and treatment programs for mothers.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT01096134
Indication
Cervical Cancer
Modality
vaccine
Target
HPV Vaccine (Gardasil)
Intervention
HPV Vaccine (Gardasil)
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.